Quantum Leap Healthcare Collaborative
The I-SPY Trials
For Patients
I-SPY Platform
I-SPY 2 Trial
Resources
Funding & Support
Agents & Results
I-SPY Agents
Manuscripts
Meeting Abstracts
Collaborate
Proposal Submissions
Partner With Us
News
Latest News
Feature Articles
I-SPY in the News
Media Center
People
Leadership
Clinical Sites
Contact Us
FOR PATIENTS
News
I-SPY in the News
Widely hailed as the future of phase II drug development, the adaptive I-SPY2 platform trial has set a new benchmark for efficiency, through innovation in trial design and clinical operations.
Close
Close
Close
I-SPY Email List Sign-up
First Name:
Last Name:
Email Address:
Breast cancer patient/family/friend
Research/Medical Professional
Just Interested
Thank you, your subscription is activated.
If you change your mind, you can
unsubscribe
at any time.
Oops! Something went wrong while submitting the form.
Highlights
Dr. Laura Esserman among recipients of 2020 Brinker Awards for Scientific Distinction
October 1, 2020
Genomic Testing in Breast Cancer May Enhance Personalized Treatment: Update of I-SPY 2
ASCO Post
November 28, 2018
FDA's Woodcock: 'The clinical trial system is broken'
BioPharmDrive
November 20, 2018
Recent Coverage
February 23, 2017
-
R&D Magazine
Three Skills Developers Will Need to Thrive in the New Era of Genomic Medicine
January 5, 2017
-
Huffington Post
Top Ten Medical Research Issues and Trends to Watch in 2017
October 26, 2016
-
Cancer Therapy Advisor
Adaptive randomization and the I-SPY 2 trial platform
October 26, 2016
-
Clin Adv Hem Onc
The I-SPY approach to drug development: An interview with Laura Esserman
September 5, 2016
-
BioCentury
Back to School: Haste, not waste
July 7, 2016
-
NEJM
I-SPY 2 - A glimpse of future phase 2 drug development?
June 25, 2016
-
Oncology Times
I-SPY 2 shows efficacy of T-DM1-Pertuzumab
November 2, 2015
-
Managed Care Mag.
Can Platform Trials Speed Cancer Drug Development?
September 28, 2015
-
NY Times
A breast cancer surgeon who keeps challenging the status quo
December 13, 2013
-
Wall St Journal
Two Experimental Breast-Cancer Drugs Pass Major Milestone in Study
October 2, 2010
-
Wall St Journal
A new Rx for medicine
May 1, 2010
-
Nature Biotechnology
Biomarker-led adaptive trial blazes a trail in breast cancer
Previous
Don't miss a thing! Get I-SPY results, news and event information delivered right to your inbox.
Sign Up
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.